A new treatment for postpartum depression, which affects about one in nine new mothers in the U.S., could be approved by the Food and Drug Administration this week.

The pill, called zuranolone, has shown to improve depression symptoms among new mothers as early as three days after they started it.

Support The Readers Bureau. Buy A T-Shirt Today (4 different colors)! click  https://www.bonfire.com/one-love-72/?fbclid=IwAR2bod-XSyrCPutOwG_SMnKiInk6Bqe2kCtjBsAFISqHluQcujrF2UUkFew

Readers Bureau, Contributor

 Edited by Jesus Chan

 Do you want to add feedback to this story?

Please add a comment in the box below or send an email to xdeefix@aol.com. Call us at 646-874-7976. SUBSCRIBE CLICK https://www.youtube.com/c/yvadbillingsreadersbureau

Like our Facebook page https://www.facebook.com/TheReadersBureau

Follow us on Twitter https://twitter.com/readersbureau21